Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Capital Employed (2020 - 2025)

Revolution Medicines (RVMD) has 6 years of Return on Capital Employed data on record, last reported at 0.12% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 23.0% year-over-year to 0.12%; the TTM value through Dec 2025 reached 0.12%, up 23.0%, while the annual FY2025 figure was 0.11%, 21.0% up from the prior year.
  • Return on Capital Employed reached 0.12% in Q4 2025 per RVMD's latest filing, up from 0.49% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.12% in Q4 2025 and bottomed at 0.49% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.32%, with a median of 0.34% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: decreased -19bps in 2022, then grew 23bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.28% in 2021, then fell by -23bps to 0.34% in 2022, then dropped by -4bps to 0.35% in 2023, then rose by 2bps to 0.35% in 2024, then soared by 66bps to 0.12% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.12% in Q4 2025, 0.49% in Q3 2025, and 0.41% in Q2 2025.